公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 REVVITY DO BRASIL LTDA取消

92 记录

产品持有公司班级有效性
Família PlGF (Fator de Crescimento Placentário)10298910177REVVITY DO BRASIL LTDAIII26/06/2033
Família SuperFlex D-Dimer10298910175REVVITY DO BRASIL LTDAIII03/04/2033
SuperFlex High Sensitivity Cardiac Troponin I Kit10298910176REVVITY DO BRASIL LTDAIII03/04/2033
Família SuperFlex Cardiac Troponin I10298910173REVVITY DO BRASIL LTDAIII27/03/2033
Família SuperFlex Creatine Kinase-MB10298910174REVVITY DO BRASIL LTDAIII27/03/2033
GSP® Neonatal Galactose Total kit - PN 3309-002010298910171REVVITY DO BRASIL LTDAIII04/07/2032
kit PKamp Respiratory SARS-CoV-2 RT-PCR Panel10298910168REVVITY DO BRASIL LTDAIII17/01/2032
Eonis SCID-SMA kit PN 3241-0010/ PN 3242-001010298910155REVVITY DO BRASIL LTDAIII03/05/2031
GSP Neo natal Creatine Kinase -MM PN 3311-001010298910151REVVITY DO BRASIL LTDAIII13/10/2030
NeoBase 2 Non-derivatized MSMS kit 3044-001010298910147REVVITY DO BRASIL LTDAIII27/07/2030
NEONATAL TOTAL GALACTOSE KIT10298910089REVVITY DO BRASIL LTDAIII14/04/2028
NeoLSD MSMS Kit10298910139REVVITY DO BRASIL LTDAIII02/01/2028
GSP Neonatal Phenylalanine Kit10298910119REVVITY DO BRASIL LTDAIII17/12/2027
DELFIA/AutoDELFIA PlGF Kit10298910118REVVITY DO BRASIL LTDAIII15/10/2027
DELFIA XPRESS hAFP10298910086REVVITY DO BRASIL LTDAIII08/10/2027
SOLUCAO DE LAVAGEM CONCENTRADA DELFIA10298910033REVVITY DO BRASIL LTDAI现有
SOLUÇÃO ENHANCEMENT DELFIA10298910034REVVITY DO BRASIL LTDAI现有
SOLUCAO PADRAO EUROPIO DELFIA10298910058REVVITY DO BRASIL LTDAI现有
Sistema Autodelfia para Fluoroimunoensaio10298910066REVVITY DO BRASIL LTDAII现有
DELFIA XPRESS 6000-01010298910074REVVITY DO BRASIL LTDAII现有
DELFIA DILUENTE 310298910084REVVITY DO BRASIL LTDAI现有
DELFIA INDUCER10298910087REVVITY DO BRASIL LTDAI现有
DELFIA WASH CONCENTRATE10298910090REVVITY DO BRASIL LTDAI现有
NeoBase Non-derivatized Assay Solutions10298910096REVVITY DO BRASIL LTDAI现有
NeoBase Succinylacetone Assay Solution10298910098REVVITY DO BRASIL LTDAI现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家